HEADER TRANSFERASE 27-NOV-15 5FP6 TITLE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH SMALL-MOLECULE LIGAND 3- TITLE 2 (4,7-DICHLORO-1H-INDOL-3-YL)PROP-2-YN-1-OL (AT17833) IN AN ALTERNATE TITLE 3 BINDING SITE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2, P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS TRANSFERASE, KINASE, MITOSIS, CELL CYCLE, FRAGMENT SCREENING, KEYWDS 2 ALTERNATE BINDING SITE. EXPDTA X-RAY DIFFRACTION AUTHOR H.JHOTI,R.F.LUDLOW,M.O'REILLY,H.K.SAINI,I.J.TICKLE,M.VERDONK REVDAT 4 10-JAN-24 5FP6 1 REMARK REVDAT 3 28-APR-21 5FP6 1 REMARK REVDAT 2 13-JAN-16 5FP6 1 JRNL REVDAT 1 23-DEC-15 5FP6 0 JRNL AUTH R.F.LUDLOW,M.L.VERDONK,H.K.SAINI,I.J.TICKLE,H.JHOTI JRNL TITL DETECTION OF SECONDARY BINDING SITES IN PROTEINS USING JRNL TITL 2 FRAGMENT SCREENING. JRNL REF PROC.NATL.ACAD.SCI.USA V. 112 15910 2015 JRNL REFN ISSN 0027-8424 JRNL PMID 26655740 JRNL DOI 10.1073/PNAS.1518946112 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.G.WYATT,A.J.WOODHEAD,V.BERDINI,J.A.BOULSTRIDGE,M.G.CARR, REMARK 1 AUTH 2 D.M.CROSS,D.J.DAVIS,L.A.DEVINE,T.R.EARLY,R.E.FELTELL, REMARK 1 AUTH 3 E.J.LEWIS,R.L.MCMENAMIN,E.F.NAVARRO,M.A.O'BRIEN,M.O'REILLY, REMARK 1 AUTH 4 M.REULE,G.SAXTY,L.C.A.SEAVERS,D.SMITH,M.S.SQUIRES, REMARK 1 AUTH 5 G.TREWARTHA,M.T.WALKER,A.J.WOOLFORD REMARK 1 TITL IDENTIFICATION OF REMARK 1 TITL 2 N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO) REMARK 1 TITL 3 -1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN REMARK 1 TITL 4 DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY REMARK 1 TITL 5 CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. REMARK 1 REF J.MED.CHEM. V. 51 4986 2008 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 18656911 REMARK 1 DOI 10.1021/JM800382H REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 23282 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.910 REMARK 3 FREE R VALUE TEST SET COUNT : 1142 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 65.51 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1936 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2568 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1850 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE : 0.3147 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.44 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 86 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2176 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 337 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.83 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.91280 REMARK 3 B22 (A**2) : -4.67950 REMARK 3 B33 (A**2) : 2.76670 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.264 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.195 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.159 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.172 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.150 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2279 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3109 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 747 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 44 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 342 ; 16.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2279 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 294 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2965 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 0.65 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 5.72 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.51 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|1 - A|83 } REMARK 3 ORIGIN FOR THE GROUP (A): 17.6028 2.1880 64.7304 REMARK 3 T TENSOR REMARK 3 T11: -0.0765 T22: 0.0627 REMARK 3 T33: -0.0007 T12: 0.0129 REMARK 3 T13: -0.0040 T23: 0.0479 REMARK 3 L TENSOR REMARK 3 L11: 0.5958 L22: 0.0291 REMARK 3 L33: 0.3914 L12: 0.1152 REMARK 3 L13: -0.2220 L23: 0.3593 REMARK 3 S TENSOR REMARK 3 S11: -0.0037 S12: -0.0229 S13: 0.0090 REMARK 3 S21: -0.0103 S22: -0.0099 S23: 0.0406 REMARK 3 S31: -0.0024 S32: -0.0254 S33: 0.0136 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|130 - A|164 } REMARK 3 ORIGIN FOR THE GROUP (A): 31.9230 2.5875 57.7899 REMARK 3 T TENSOR REMARK 3 T11: 0.0071 T22: 0.0198 REMARK 3 T33: -0.0271 T12: 0.0294 REMARK 3 T13: 0.0037 T23: 0.0546 REMARK 3 L TENSOR REMARK 3 L11: 0.3218 L22: 0.0000 REMARK 3 L33: 0.6546 L12: 0.2024 REMARK 3 L13: -0.7171 L23: -0.1970 REMARK 3 S TENSOR REMARK 3 S11: 0.0033 S12: -0.0201 S13: 0.0047 REMARK 3 S21: 0.0133 S22: -0.0049 S23: 0.0074 REMARK 3 S31: -0.0084 S32: 0.0068 S33: 0.0016 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { A|84 - A|129 A|165 - A|294 } REMARK 3 ORIGIN FOR THE GROUP (A): 33.4831 6.6684 41.8204 REMARK 3 T TENSOR REMARK 3 T11: -0.0484 T22: -0.0213 REMARK 3 T33: -0.0371 T12: 0.0063 REMARK 3 T13: 0.0047 T23: 0.0061 REMARK 3 L TENSOR REMARK 3 L11: 1.0165 L22: 0.4794 REMARK 3 L33: 1.2655 L12: -0.1503 REMARK 3 L13: 0.3251 L23: -0.0809 REMARK 3 S TENSOR REMARK 3 S11: 0.0078 S12: 0.0180 S13: 0.0202 REMARK 3 S21: 0.0039 S22: -0.0137 S23: 0.0096 REMARK 3 S31: -0.0522 S32: 0.0531 S33: 0.0058 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 5FP6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1290065636. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK 9.7 REMARK 200 DATA SCALING SOFTWARE : DTSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24694 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 32.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CSEARCH REMARK 200 STARTING MODEL: PDB ENTRY 5FP5 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN CONCENTRATION: 13.6 MG/ML, PH REMARK 280 7.4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.95850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.09900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.10700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.09900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.95850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.10700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 148 REMARK 465 ALA A 149 REMARK 465 ARG A 150 REMARK 465 ALA A 151 REMARK 465 PHE A 152 REMARK 465 GLY A 153 REMARK 465 VAL A 154 REMARK 465 PRO A 155 REMARK 465 VAL A 156 REMARK 465 ARG A 157 REMARK 465 THR A 158 REMARK 465 TYR A 159 REMARK 465 THR A 160 REMARK 465 HIS A 161 REMARK 465 GLU A 162 REMARK 465 VAL A 163 REMARK 465 HIS A 295 REMARK 465 LEU A 296 REMARK 465 ARG A 297 REMARK 465 LEU A 298 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 1 CE REMARK 470 LYS A 6 NZ REMARK 470 LYS A 9 CE NZ REMARK 470 GLU A 12 CD OE1 OE2 REMARK 470 LEU A 25 CG CD1 CD2 REMARK 470 ARG A 36 CD NE CZ NH1 NH2 REMARK 470 GLU A 40 CD OE1 OE2 REMARK 470 ARG A 50 CD NE CZ NH1 NH2 REMARK 470 ASN A 59 CG OD1 ND2 REMARK 470 LYS A 65 CE NZ REMARK 470 LYS A 88 CD CE NZ REMARK 470 LYS A 89 CD CE NZ REMARK 470 LEU A 96 CD1 CD2 REMARK 470 ARG A 122 CD NE CZ NH1 NH2 REMARK 470 VAL A 164 CG1 CG2 REMARK 470 LYS A 178 CD CE NZ REMARK 470 LYS A 242 NZ REMARK 470 ASP A 247 CG OD1 OD2 REMARK 470 LYS A 278 CD CE NZ REMARK 470 GLN A 287 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 122 47.15 38.71 REMARK 500 ARG A 126 -20.61 83.61 REMARK 500 ASP A 127 47.24 -142.94 REMARK 500 TYR A 179 53.72 -114.27 REMARK 500 PRO A 254 35.91 -99.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2041 DISTANCE = 6.21 ANGSTROMS REMARK 525 HOH A2105 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH A2138 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH A2167 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH A2336 DISTANCE = 6.90 ANGSTROMS REMARK 525 HOH A2337 DISTANCE = 6.18 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 3-(4,7-DICHLORO-1H-INDOL-3-YL)PROP-2-YN-1-OL (MFZ): ASTEX REMARK 600 COMPOUND REGISTRY AT17833 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MFZ A 1295 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MFZ A 1296 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FP5 RELATED DB: PDB REMARK 900 STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH SMALL- MOLECULE LIGAND REMARK 900 4-FLUOROBENZOIC ACID (AT222) IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPD RELATED DB: PDB REMARK 900 STRUCTURE OF HEAT SHOCK-RELATED 70KDA PROTEIN 2 WITH SMALL-MOLECULE REMARK 900 LIGAND PYRAZINE-2-CARBOXAMIDE (AT513) IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPE RELATED DB: PDB REMARK 900 STRUCTURE OF HEAT SHOCK-RELATED 70KDA PROTEIN 2 WITH SMALL-MOLECULE REMARK 900 LIGAND 1H-1,2,4-TRIAZOL-3-AMINE ( AT485) IN AN ALTERNATE BINDING REMARK 900 SITE. REMARK 900 RELATED ID: 5FPM RELATED DB: PDB REMARK 900 STRUCTURE OF HEAT SHOCK-RELATED 70KDA PROTEIN 2 WITH SMALL-MOLECULE REMARK 900 LIGAND 5-PHENYL-1,3,4-OXADIAZOLE-2- THIOL (AT809) IN AN ALTERNATE REMARK 900 BINDING SITE. REMARK 900 RELATED ID: 5FPN RELATED DB: PDB REMARK 900 STRUCTURE OF HEAT SHOCK-RELATED 70KDA PROTEIN 2 WITH SMALL-MOLECULE REMARK 900 LIGAND 3,5-DIMETHYL-1H-PYRAZOLE-4- CARBOXYLIC ACID (AT9084) IN AN REMARK 900 ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPO RELATED DB: PDB REMARK 900 STRUCTURE OF BACTERIAL DNA LIGASE WITH SMALL-MOLECULE LIGAND 1H- REMARK 900 INDAZOL-7-AMINE (AT4213) IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPR RELATED DB: PDB REMARK 900 STRUCTURE OF BACTERIAL DNA LIGASE WITH SMALL-MOLECULE LIGAND REMARK 900 PYRIMIDIN-2-AMINE (AT371) IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPS RELATED DB: PDB REMARK 900 STRUCTURE OF HEPATITIS C VIRUS (HCV) FULL-LENGTH NS3 COMPLEX WITH REMARK 900 SMALL-MOLECULE LIGAND 3-AMINOBENZENE-1,2 -DICARBOXYLIC ACID (AT1246) REMARK 900 IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPT RELATED DB: PDB REMARK 900 STRUCTURE OF HEPATITIS C VIRUS (HCV) FULL-LENGTH NS3 COMPLEX WITH REMARK 900 SMALL-MOLECULE LIGAND 2-(1-METHYL-1H- INDOL-3-YL)ACETIC ACID REMARK 900 (AT3437) IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPY RELATED DB: PDB REMARK 900 STRUCTURE OF HEPATITIS C VIRUS (HCV) FULL-LENGTH NS3 COMPLEX WITH REMARK 900 SMALL-MOLECULE LIGAND 5-BROMO-1-METHYL- 1H-INDOLE-2-CARBOXYLIC ACID REMARK 900 (AT21457) IN AN ALTERNATE BINDING SITE. DBREF 5FP6 A 1 298 UNP P24941 CDK2_HUMAN 1 298 SEQRES 1 A 298 MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU GLY SEQRES 2 A 298 THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU THR SEQRES 3 A 298 GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP THR SEQRES 4 A 298 GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU ILE SEQRES 5 A 298 SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 6 A 298 LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR LEU SEQRES 7 A 298 VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE MET SEQRES 8 A 298 ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU ILE SEQRES 9 A 298 LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA PHE SEQRES 10 A 298 CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 11 A 298 GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS LEU SEQRES 12 A 298 ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO VAL SEQRES 13 A 298 ARG THR TYR THR HIS GLU VAL VAL THR LEU TRP TYR ARG SEQRES 14 A 298 ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER THR SEQRES 15 A 298 ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA GLU SEQRES 16 A 298 MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER GLU SEQRES 17 A 298 ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY THR SEQRES 18 A 298 PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET PRO SEQRES 19 A 298 ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN ASP SEQRES 20 A 298 PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY ARG SEQRES 21 A 298 SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN LYS SEQRES 22 A 298 ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE PHE SEQRES 23 A 298 GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU HET MFZ A1295 22 HET MFZ A1296 22 HETNAM MFZ 3-(4,7-DICHLORO-1H-INDOL-3-YL)PROP-2-YN-1-OL FORMUL 2 MFZ 2(C11 H7 CL2 N O) FORMUL 4 HOH *337(H2 O) HELIX 1 1 ASP A 38 VAL A 44 1 7 HELIX 2 2 PRO A 45 LEU A 58 1 14 HELIX 3 3 LEU A 87 SER A 94 1 8 HELIX 4 4 PRO A 100 HIS A 121 1 22 HELIX 5 5 LYS A 129 GLN A 131 5 3 HELIX 6 6 ALA A 170 LEU A 175 1 6 HELIX 7 7 THR A 182 ARG A 199 1 18 HELIX 8 8 SER A 207 GLY A 220 1 14 HELIX 9 9 GLY A 229 MET A 233 5 5 HELIX 10 10 ASP A 247 VAL A 252 1 6 HELIX 11 11 ASP A 256 LEU A 267 1 12 HELIX 12 12 SER A 276 ALA A 282 1 7 HELIX 13 13 HIS A 283 GLN A 287 5 5 SHEET 1 AA 5 PHE A 4 GLU A 12 0 SHEET 2 AA 5 GLY A 16 ASN A 23 -1 O VAL A 18 N ILE A 10 SHEET 3 AA 5 VAL A 29 ARG A 36 -1 O VAL A 30 N ALA A 21 SHEET 4 AA 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 AA 5 LEU A 66 THR A 72 -1 N LEU A 67 O VAL A 79 SHEET 1 AB 3 GLN A 85 ASP A 86 0 SHEET 2 AB 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AB 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 CISPEP 1 PRO A 253 PRO A 254 0 -1.58 SITE 1 AC1 11 ILE A 10 GLY A 13 VAL A 18 ALA A 31 SITE 2 AC1 11 GLU A 81 PHE A 82 LEU A 83 LEU A 134 SITE 3 AC1 11 ASP A 145 HOH A2021 HOH A2123 SITE 1 AC2 7 PRO A 45 ILE A 49 HIS A 71 LEU A 76 SITE 2 AC2 7 PRO A 228 GLY A 229 HOH A2085 CRYST1 53.917 72.214 72.198 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018547 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013848 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013851 0.00000